BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 30913928)

  • 1. Comparative financing analysis and political economy of noncommunicable diseases.
    Jakovljevic M; Jakab M; Gerdtham U; McDaid D; Ogura S; Varavikova E; Merrick J; Adany R; Okunade A; Getzen TE
    J Med Econ; 2019 Aug; 22(8):722-727. PubMed ID: 30913928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financing national non-communicable disease responses.
    Allen LN
    Glob Health Action; 2017; 10(1):1326687. PubMed ID: 28604238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review on Noncommunicable Diseases (NCDs) burden, its socio-economic impact and the strategies for prevention and control of NCDs in India.
    Kundu MK; Hazra S; Pal D; Bhattacharya M
    Indian J Public Health; 2018; 62(4):302-304. PubMed ID: 30539894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The household financial burden of non-communicable diseases in low- and middle-income countries: a systematic review.
    Kazibwe J; Tran PB; Annerstedt KS
    Health Res Policy Syst; 2021 Jun; 19(1):96. PubMed ID: 34154609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Global South political economy of health financing and spending landscape - history and presence.
    Jakovljevic M; Liu Y; Cerda A; Simonyan M; Correia T; Mariita RM; Kumara AS; Garcia L; Krstic K; Osabohien R; Toan TK; Adhikari C; Chuc NTK; Khatri RB; Chattu VK; Wang L; Wijeratne T; Kouassi E; Khan HN; Varjacic M
    J Med Econ; 2021 Nov; 24(sup1):25-33. PubMed ID: 34866543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The global impact of non-communicable diseases on households and impoverishment: a systematic review.
    Jaspers L; Colpani V; Chaker L; van der Lee SJ; Muka T; Imo D; Mendis S; Chowdhury R; Bramer WM; Falla A; Pazoki R; Franco OH
    Eur J Epidemiol; 2015 Mar; 30(3):163-88. PubMed ID: 25527371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introducing the PLOS special collection of economic cases for NCD prevention and control: A global perspective.
    Nugent RA; Husain MJ; Kostova D; Chaloupka F
    PLoS One; 2020; 15(2):e0228564. PubMed ID: 32027710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who is bearing the financial burden of non-communicable diseases in Mongolia?
    Dugee O; Palam E; Dorjsuren B; Mahal A
    J Glob Health; 2018 Jun; 8(1):010415. PubMed ID: 29564086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial risk protection against noncommunicable diseases: trends and patterns in Bangladesh.
    Rahman T; Gasbarro D; Alam K
    BMC Public Health; 2022 Sep; 22(1):1835. PubMed ID: 36175951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The global impact of non-communicable diseases on healthcare spending and national income: a systematic review.
    Muka T; Imo D; Jaspers L; Colpani V; Chaker L; van der Lee SJ; Mendis S; Chowdhury R; Bramer WM; Falla A; Pazoki R; Franco OH
    Eur J Epidemiol; 2015 Apr; 30(4):251-77. PubMed ID: 25595318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-communicable diseases and health systems reform in low-and-middle-income countries.
    Robinson HM; Hort K
    Pac Health Dialog; 2012 Apr; 18(1):179-90. PubMed ID: 23240355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating tuberculosis and noncommunicable diseases care in low- and middle-income countries (LMICs): A systematic review.
    Foo C; Shrestha P; Wang L; Du Q; GarcĂ­a-Basteiro AL; Abdullah AS; Legido-Quigley H
    PLoS Med; 2022 Jan; 19(1):e1003899. PubMed ID: 35041654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050.
    Global Burden of Disease 2020 Health Financing Collaborator Network
    Lancet; 2021 Oct; 398(10308):1317-1343. PubMed ID: 34562388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and prioritization of the WHO "best buys" and other recommended interventions for the prevention and control of non-communicable diseases in Iran.
    Bakhtiari A; Takian A; Majdzadeh R; Haghdoost AA
    BMC Public Health; 2020 Mar; 20(1):333. PubMed ID: 32171267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consumption displacement in households with noncommunicable diseases in Bangladesh.
    Datta BK; Husain MJ; Fatehin S; Kostova D
    PLoS One; 2018; 13(12):e0208504. PubMed ID: 30543648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mongolia's Public Spending On Noncommunicable Diseases Is Similar To The Spending Of Higher-Income Countries.
    Dugee O; Munaa E; Sakhiya A; Mahal A
    Health Aff (Millwood); 2017 May; 36(5):918-925. PubMed ID: 28461360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The household economic burden of non-communicable diseases in 18 countries.
    Murphy A; Palafox B; Walli-Attaei M; Powell-Jackson T; Rangarajan S; Alhabib KF; Avezum AJ; Calik KBT; Chifamba J; Choudhury T; Dagenais G; Dans AL; Gupta R; Iqbal R; Kaur M; Kelishadi R; Khatib R; Kruger IM; Kutty VR; Lear SA; Li W; Lopez-Jaramillo P; Mohan V; Mony PK; Orlandini A; Rosengren A; Rosnah I; Seron P; Teo K; Tse LA; Tsolekile L; Wang Y; Wielgosz A; Yan R; Yeates KE; Yusoff K; Zatonska K; Hanson K; Yusuf S; McKee M
    BMJ Glob Health; 2020; 5(2):e002040. PubMed ID: 32133191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action to address the household economic burden of non-communicable diseases.
    Jan S; Laba TL; Essue BM; Gheorghe A; Muhunthan J; Engelgau M; Mahal A; Griffiths U; McIntyre D; Meng Q; Nugent R; Atun R
    Lancet; 2018 May; 391(10134):2047-2058. PubMed ID: 29627161
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.